On September 25, 2024, the U.S. Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for people with unresectable stage 3 (III) non-small cell lung cancer (NSCLC). It’s approved for people who have both: Disease that has not progressed during [...]
By Tamara Gabrielli, MD Dr. Gabrielli recently retired after a 30-year career as an anesthesiologist in Maryland and Washington, D.C. She lives in Rockville, MD and has three daughters in their 20s. She just celebrated her 64th birthday. [...]
Authors: Renee Botello, MSc., Treatment and Trials Navigator; Andrew Ciupek, PhD, Associate Director, Clinical Research; Chief Scientific Officer Jennifer C. King, PhD; Shanada Monestime, PharmD, BCOP, Director, Community Engaged Research Every person’s cancer is different, which is why we [...]
Hi, I'm Anne Charity Hudley, Ph.D., the North Hall Endowed Chair in the Linguistics of African America and the former Director of Undergraduate Research for the Office of Undergraduate Education at the University of California, Santa Barbara. I study [...]